Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Hypoglycemia01:26

Hypoglycemia

30
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

5.3K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

1.6K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetic striatopathy associated with nonketotic hyperglycemia.

JCEM case reports·2026
Same author

Insulin Pump Therapy in the Hospital.

The Medical clinics of North America·2026
Same author

Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

GLM-DM: language model boosted neural networks for HbA1c trend prediction in diabetes mellitus.

Future science OA·2025
Same author

Assessing the Complexity of Inpatient Care Managed by Endocrinologists in a Tertiary Care Teaching Hospital.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same author

A Community-Based Intervention to Address Social Determinants of Health: A Pilot Study.

Joint Commission journal on quality and patient safety·2025

Related Experiment Video

Updated: May 2, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Benchmarking glycemic control in u.s. Hospitals.

Sophie Bersoux1, Curtiss B Cook2, Gail L Kongable3

  • 1Division of Community Internal Medicine, Mayo Clinic, Scottsdale, Arizona.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|March 20, 2014
PubMed
Summary

Glucose control in U.S. hospitals varies by facility characteristics. This analysis of point-of-care blood glucose data reveals differences in hyperglycemia and hypoglycemia rates based on hospital size, location, and patient type.

More Related Videos

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

8.8K

Related Experiment Videos

Last Updated: May 2, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

8.8K

Area of Science:

  • Clinical Medicine
  • Endocrinology
  • Hospital Management

Background:

  • Effective inpatient glucose control is crucial for patient outcomes.
  • Variability in glucose management strategies across hospitals is poorly understood.
  • Point-of-care blood glucose (POC-BG) monitoring is widely used in U.S. hospitals.

Purpose of the Study:

  • To analyze glucose control data from a large cohort of U.S. hospitals.
  • To identify variations in glycemic control based on hospital characteristics.
  • To assess the prevalence of hyperglycemia and hypoglycemia in non-intensive care unit (ICU) and ICU patients.

Main Methods:

  • Extracted POC-BG test data from 635 U.S. hospitals (January-December 2012).
  • Evaluated glucose control using patient-day-weighted mean POC-BG values.
  • Calculated hypoglycemia (<70 mg/dL) and hyperglycemia (>180 mg/dL) rates, stratified by ICU admission.

Main Results:

  • Analyzed over 51 million POC-BG measurements from 2.6 million patients.
  • Mean POC-BG was 167 mg/dL (non-ICU) and 170 mg/dL (ICU).
  • Hyperglycemia prevalence: 32.3% (non-ICU), 28.2% (ICU). Hypoglycemia prevalence: 6.1% (non-ICU), 5.6% (ICU).
  • Glycemic control varied significantly by hospital size, type, and geographic region (P<.01).
  • Hypoglycemia rates differed by geographic region in non-ICU patients (P<.001) and by hospital type and region in ICU patients (P<.03, P<.01).

Conclusions:

  • Glycemic control in U.S. hospitals is influenced by hospital characteristics.
  • Findings align with previous research on inpatient glucose management.
  • National benchmarking of inpatient glucose data must account for hospital-specific factors.